Stereotactic Ablative Radiotherapy, “Microbeam” Boost, “Overtreatment”, and “Limited Life Expectancy”: Flawed Terminology in an Increasingly Precise Field of Prostate Cancer

Technological advancements have firmly established radiation therapy as a cornerstone of cancer treatment. This is particularly true for prostate cancer, where radiation therapy is often employed with curative intent. These innovations have given rise to terminologies that have sparked debates and differing opinions. In this context, we explore some of these terms and address the challenges they present. Finally, we propose clarifications that we believe can guide these debates toward more constructive and meaningful discussions.